Neural crest cells (NCCs) are highly pluripotent stem cell populations that arise from the neural folds and migrate extensively to different regions, where they differentiate into a broad range of cell types to build up various structures. The cranial NCCs (CNCCs) originate from posterior forebrain and posterior hindbrain and contribute to much of bones, cartilages, cranial nerves, muscles and connective tissues in face and neck. [1] [2] [3] [4] During vertebrate craniofacial development, the specification, migration, proliferation and differentiation of CNCCs are tightly controlled by a spatial and temporal signaling network. 5 Aberrations in any node of these signaling networks could result in craniofacial malformations, such as cleft lip, cleft palate and mandibular hypoplasia.
The Pierre Robin Sequence (PRS) is a human craniofacial malformation (OMIM: 261800) characterized by U-shaped cleft palate, glossoptosis (backward displacement of the tongue) and micrognathia (abnormally small mandible). [6] [7] [8] PRS occurs with an incidence of 1 : 8500 to 1 : 14 000 in live births and results in severe respiratory distress and feeding difficulties in infants. 6, 9, 10 Mutations in several genes, including BMP2, SATB2, COL2A1, COL11A1, COL11A2, SOX9 and KCNJ2, have been identified in PRS. [11] [12] [13] [14] [15] Mandibular growth retardation is considered to be the most possible cause for PRS-cleft palate. 7 In mammals, Meckel's cartilage has a close relation to the mandibular development. During embryonic development, the extension of Meckel's cartilage within the mandibular prominence promotes the elongation of mandible, which subsequently assists the flattening of tongue and permits the elevation and followed fusion of palatal shelves. 7, 16 Multiple genetic evidences have demonstrated that defective mandible and Meckel's cartilage development could lead to cleft palate. 7, [17] [18] [19] [20] [21] [22] Transferrin receptor (Tfrc) is a homodimeric transmembrane glycoprotein that binds to iron-bound transferrin and mediates the extracellular iron to be delivered into cells via clathrin-dependent endocytosis. 23, 24 Although Tfrc is widely believed to be important for iron acquisition by all mammalian cells, its physiological function for mammal's development is poorly understood. Here, we report that Tfrc is necessary for embryonic craniofacial development. Mice lacking Tfrc in NCCs exhibit micrognathia, cleft palate, severe respiratory distress and inability to suckle, which highly resemble human PRS. Histological and anatomical analysis revealed that cleft palate results from the failure of palatal shelves elevation, furthermore the failed palatal shelves elevation is due to retarded extension of Meckel's cartilage that is essential for mandible elongation. Molecularly, the ablation of Tfrc in NCCs significantly suppressed transforming growth factor-β (ΤGF-β) and BMP signaling in NCCs-derived mandibular tissues. Based on these data, we propose that Tfrc is a facilitator of TGF-β and BMP signaling and Tfrc-mediated activation of these two signaling pathways is essential for craniofacial morphogenesis.
Results
Tfrc deletion in NCCs causes craniofacial defects. Although Tfrc has been studied extensively, the potential role of Tfrc in regulating NCCs development remains unclear. Therefore, we first examined the expression pattern of Tfrc during NCCs development by immunofluorescent staining. Sections from embryonic day 9.5 (E9.5) wild-type embryos were labeled with Tfrc and transcription factor activator protein 2α (AP-2α) antibodies, a marker for premigratory and migratory NCCs. 25, 26 Tfrc was broadly and highly expressed in regions populated by cells of neural crest origin, including brachial arch (BA1), frontonasal prominence (FNP) and dorsal root ganglia ( Figure 1a ). In these regions, Tfrc showed a clustered expression pattern in cytoplasm (Figure 1b) .
Besides its expression in NCCs-derived cells, Tfrc is expressed broadly during development, therefore it is not surprising that mice deficient for the Tfrc gene die before E12.5. 27 To circumvent this early lethality and investigate the function of Tfrc in NCCs, we generated NCCs-specific (Figures 1d and e) , incomplete oral closure (Figure 1e ), severe respiratory distress (Supplementary Material and Supplementary Movie 1) and inability to suckle, highly resembling the human PRS. Due to these severe defects, the mutant pups sucked air rather than milk into their gastrointestinal tract (Figures 1f and g ). The morphologies of other tissues derived from NCCs were also examined in postnatal day 0 (P0) mutant pups. As shown, Tfrc KO in NCCs did not induce abnormalities in these tissues, including craniofacial nerves (Supplementary Figures S1A and B (Figures 2a and b) . To determine the onset of cleft palate in mutants, the developments of palate at various embryonic stages were examined by histological staining. In E13.5 controls, the palatal shelves grew vertically down to the two sides of tongue ( Figure 2c) ; then at E14.5, they rotated to a horizontal position above tongue and elongated to fuse with remnant medial edge epithelium (MEE) (Figure 2e ), finally the E16.5 and P0 controls exhibited completely fused palate with flat tongues (Figures 2g and i) . However, this process was disrupted by Tfrc deletion. The palatal shelves in E13.5 Wnt1 cre ;Tfrc f/f mutants were welldeveloped and properly extended to the two sides of tongue (Figure 2d ), but they failed to elevate above the tongue (Figure 2f) , and consequently the E16.5 and P0 mutants displayed cleft palates with arched tongues (Figures 2h  and j) . The normal initiation of palatal bone were formed by mesenchymal cells both in Wnt1 cre ;Tfrc f/f mutants and controls (Figures 2e and f) , suggesting that Tfrc is not essential for palatal bone initiation but palatal fusion. Next, to examine the ability to fuse for palatal shelves in vitro, we performed the palatal shelves culture assay. In brief, palatal shelves were dissected from E13.5 embryos and placed in pairs on Millipore filters (EMD Millipore, Merck, KGaA, Darmstadt, Germany) with correct anterior-posterior orientation. By 3 days in culture, all these palatal shelves from Wnt1 cre ;Tfrc f/f mutants and control littermates fused completely with normal disappearance of MEE (Figures 2k and l) , suggesting that palatal shelves in Wnt1 cre ;Tfrc f/f mutants retain the ability to fuse. In addition, formation of osteoid-like structures were observed in both control and mutant palatal mesenchyme (Figures 2k and l) , indicating that the palatal bone initiation was not Tfrc dependent. Together, these results suggest that Tfrc depletion in NCCs leads to failed elevation of palatal shelves and thereby causes cleft palate.
Craniofacial skeletons are malformed in Wnt1 cre ;Tfrc f/f mutants. To examine the morphologies of craniofacial skeletons, whole-mount pups of Wnt1 cre ;Tfrc f/f mutants and control littermates were stained with Alcian blue and Alizarin red to reveal cartilages and bones, respectively. In a line with the observed micrognathia in newborn mutant pups, the mandibular bones in Wnt1 cre ;Tfrc f/f mutant were significantly shorter than that in control (Figures 3a and b) . The secondary cartilage of angular process was nearly missing, while the mandibular condyle and coronoid process were also severely blocked/delayed by Tfrc deletion (Figures 3c and d) . Moreover, the mandibular bones in Wnt1 cre ;Tfrc f/f mutant were excessively curved, which consequently widened the distance between bilateral mandibular bones (Figures 3e and f) . The hyoid bone (Figure 3h ), tympanic ring and gonial bone ( Figure 3j ) were also deformed in Wnt1 cre ;Tfrc f/f mutant when compared with that in control (Figures 3g and i) . The cartilages of nasal capsule and gross morphologies of maxillary bones in Wnt1 cre ;Tfrc f/f mutant and control were comparable (Figures 3k and l) . The palatal process of palatine (pppl) and palatal process of maxilla (ppmx) extended horizontally and eventually fused to form the secondary palate (Figures 3k and m) in control. In contrast, these processes for secondary palate formation were disrupted in Wnt1 cre ;Tfrc f/f mutant, both pppl and ppmx failed to elevate or fuse (Figures 3l and n) .
NCCs-derived Meckel's cartilage is a significant determinant for mandibular development due to its inductive competence of initiating and regulating the ossification of mandible. 30 To test whether the mandible defect was caused by abnormal development of Meckel's cartilage, we carefully analyzed the effect of Tfrc KO on developmental process of Meckel's cartilage. In contrast to that Meckel's cartilages were well-developed and extended from the symphysis of mandibular bones to malleus in P0 control (Figure 3o (Figure 3r ). Moreover, the Meckel's cartilages in mutant were not fused at the distal tip when compared with that in control (Figures 3s and t Cleft palate in Wnt1 cre ;Tfrc f/f mutant is secondary to mandibular defects. It has been documented that normal mandibular development is required for palate formation. Extension of Meckel's cartilage promotes the forward growth and elongation of lower jaw, which allows the reposition of tongue from its arched pattern to a flatten position in oral cavity and permits the subsequent palatal shelves elevation and fusion. 7, 16 Given that the cleft palate phenotype in Wnt1 cre ;Tfrc f/f mutant was tightly accompanied by shortened mandible and less matured Meckel's cartilage, we wondered whether the cleft palate is a secondary effect resulting from mandibular defects. To address this question, we employed Nestin-cre mediated Tfrc KO mice (Nestin cre ;Tfrc
). Wnt1-cre-driven deletion of Tfrc occurs both in mandible and palatal mesenchyme, Nestin-cre-mediated Tfrc ablation happens in the mesenchyme and epithelium of palatal shelves but not in mandible. 31 We observed that the newborn Nestin cre ;Tfrc f/f mutant does not phenocopy the Wnt1 cre ;Tfrc f/f mutant but displays normal palatogenesis (Supplementary Figure S2 ). This result suggests that cleft palate in Wnt1 cre ; Tfrc f/f mutant is not caused by intrinsic defects within palate but most probably is a secondary defect resulting from mandibular defects.
NCC-specific deletion of Tfrc does not affect craniofacial NCCs migration or proliferation. To explore the possible cellular mechanism by which Tfrc controls mandibular development, we first examine whether Tfrc regulates CNCCs migration. Whole-mount AP-2α staining in E9.5 and E10.5 embryos was performed to track the migratory CNCCs, and the results showed comparable expression level and distribution pattern of AP-2α in Wnt1 cre ;Tfrc f/f mutants and control littermates (Figures 4a and b (Figures 4c and d) . Next, we examined whether cell proliferation was affected by the loss of Tfrc. The NCC-derived mesenchymal cell proliferation rate within mandibular regions, as measured by BrdU (5-bromo-2ʹ-deoxy-uridine) incorporation, was similar between E13.5 Tfrc is required for osteochondrogenic differentiation. To investigate whether the mandibular cartilage and bone defects in Wnt1 cre ;Tfrc f/f mutants were due to abnormal osteochondrogenic differentiation, we analyzed the expression of marker genes that are required for osteochondrogenic differentiation in E13.5 mandibular tissues by RT-qPCR. The mRNA levels of chondrocyte genes Sox9 and Col2a1, and osteoblast gene ALP and osteocalcin were all decreased in ;Tfrc f/f mutant. Scale bar, 1mm (a-f, q and r), 3 mm (g-j), 1.5 mm (k and l), 4.5 mm (m and n), 2 mm (o and p, s and t). ang.sc, secondary cartilage of the angular process of mandible; cond, condylar process of the mandible; cor, coronoid process of the mandible; gh, greater horn of hyoid; h, hyoid; lh, lesser horn of hyoid; Mec.ae, anterior extremity of the Meckel's cartilage; nc, nasal capsule; ns, nasal septum; pmx, premaxilla; ppmx, palatal process of maxilla; pppl, palatal process of palatine; pppx, palatal process of premaxilla; th, thyroid cartilage
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cre ;Tfrc f/f mutants (Figure 5a ), suggesting an osteochondrogenesis defect in Wnt1 cre ;Tfrc f/f mandible. To examine whether Tfrc directly regulates osteochondrogenic differentiation, in vitro osteochondrogenic differentiation assay was performed using mesenchymal cells isolated from control and Tfrc mutant mandible. On induction of differentiation in medium with β-glycerophosphate and ascorbic acid, control cells showed time-dependent cartilage matrix depositions and mineralized matrix depositions (Figures 5c-f ). In contrast, these depositions were reduced in Tfrc KO cells (Figures 5c-f) , suggesting a requirement of Tfrc for osteochondrogenic differentiation. Moreover, expression of Sox9, Col2a1 and ALP was decreased in Tfrc KO cells (Figure 5b) , which further supports for a differentiation defect induced by Tfrc deletion. Therefore, these results indicate that Tfrc is required for chondrogenic and osteogenic cell differentiation.
Tfrc deletion suppressed TGF-β and BMP signaling in mandible. A couple of signaling pathways including Wnt/β-catenin, Sonic hedgehog (Shh), endothelin, fibroblast growth factor (FGF) family and ΤGF-β superfamily have been implicated as critical regulators for craniofacial development. We then tested whether Tfrc regulates craniofacial development through these signaling pathways. Axin2, Ptch1, Dlx1, Gsc and Runx2, which are, respectively, typical downstream target of the indicated five pathways, were selected for expression analysis by using RT-qPCR. As shown, only Runx2, a target gene of TGF-β superfamily signaling, was downregulated in Wnt1 cre ;Tfrc f/f mutants (Figure 6a ). Protein expression levels of TGF-βR2, BMPR2 and Runx2 were all decreased in Wnt1 cre ;Tfrc f/f mutants mandibular tissue; moreover, phosphorylation of smad2 and smad5 (P-samd5 and P-smad2), which, respectively, represents the activation of TGF-β and BMP signaling, were also hugely reduced (Figures 6b and c) , suggesting that Tfrc is required for the activation of TGF-β and BMP signaling. Next, we confirmed this result in cultured mandibular mesenchymal cells. Results showed that Tfrc deletion dramatically suppressed the phosphorylation of smad5 and smad2 induced by TGF-β and BMP2 treatment (Figures 6d and e) . Combined, these results suggest that Tfrc is critical for the activation of TGF-β and BMP signaling, and Tfrc-dependent activation of these signaling pathways likely contributes to craniofacial morphogenesis by controlling mandibular development.
Discussion
In this study, we investigated the function of Tfrc in NCCs by using a Wnt1 cre -LoxP system and found a previously unknown role of Tfrc during craniofacial development. Specific deletion of Tfrc in NCCs leads to craniofacial defects including cleft palate, severe respiratory distress and inability to suckle, resembling the human PRS (OMIM 261800 ;Tfrc f/f mutants is directly caused by failed elevation of palatal shelves, while hypoplastic mandible resulted from retarded growth of Meckel's cartilage. However, the lack of either cleft palate or hypoplastic mandible in Nestin-Cremediated Tfrc KO mice suggests a different mechanism. Considering that Wnt1-cre-driven deletion of Tfrc occurs in mandible and palatal mesenchyme, while Nestin-cremediated Tfrc ablation mainly happens in the mesenchyme and epithelium of palatal shelves but not in mandible, we propose that cleft palate in Wnt1 cre ;Tfrc f/f mutant is a second consequence due to mandibular development defects. Mechanistically, Tfrc KO in NCCs primarily reduce the extension of Meckel's cartilage that is required for correct forward growth and elongation of lower jaw, then consequently cause mandibular hypoplasia. As a second result, defective mandibular maturation restricts the elevation of palatal shelves from vertical to horizontal position and then leads to cleft palate in Wnt1 cre ;Tfrc f/f mutants. Our finding is consistent to previous reports that obstruction of mandibular growth leads to cleft palate in several mutants, such as Hoxa2
Cre ;Alk2 flox/flox mutants, 19 Snai1
Gt683Lex mutants 21 and Ptprs 22 Interestingly, cleft palate in human PRS is also due to the failure of tongue translocation or mandibular growth defects, suggesting that Wnt1 cre ;Tfrc f/f mutant mice not only morphologically but also mechanistically resemble human PRS.
What is the cellular mechanism for mandibular defects in Wnt1 cre ;Tfrc f/f mutant? Fine control of NCC migration, proliferation and differentiation is essential for Meckel's cartilage processing and mandible elongation. Our analysis revealed that Tfrc is not required for NCCs migration or proliferation.
However, the differentiation of chondrogenic and osteogenic cell within mandible are severely suppressed by Tfrc deletion ( Figure 5 ). Further molecular analysis showed that the levels of Sox9, Col2a1, ALP and Osteocalcin, which are highly expressed within differentiated cells, are decreased in Tfrc KO cells (Figures 5a and b) , confirming that the differentiation process is delayed by Tfrc ablation. Thus, these results indicate that the hypoplastic mandible in Wnt1 cre ;Tfrc f/f mutant is likely a result of impaired chondrogenic and osteogenic differentiation.
What is the molecular mechanism for mandibular defects in Wnt1 cre ;Tfrc f/f mutant? TGF-β superfamily signaling is known to perform essential roles in mandible and Meckel's cartilage development. Disruption of TGF-β superfamily signaling by either complete or conditional inactivation of Bmp4, TGF-β2, TGF-βR2, Alk5, Alk2 or Smad4 results in abnormal development of Meckel's cartilage and mandible, which lead to cleft palate. 19, [32] [33] [34] [35] [36] [37] In the present study, we found that Tfrc deletion in NCCs dramatically suppresses both TGF-β and BMP Mandibular mesenchymal cells were cultured and induced to undergo osteochondrogenic differentiation for 7 days, then treated with BMP2 (100 ng/ml) or Tgfβ3 (50 ng/ml) for 30 min at 37°C. Data shown are normalized ratio of KO/Control (mean ± S.E.M); student's t-test; *Po0.05; **Po0.01; n = 3 signaling. In consistence, Tfrc KO mice show cleft palate and hypoplastic mandible that are similar to the phenotypes observed in mice lacking TGF-β or BMP signaling. Our data thus suggest that Tfrc is a critical regulator for TGF-β superfamily signaling activation during craniofacial development.
How does Tfrc control TGF-β superfamily signaling? Here, we speculate that Tfrc may control the endocytosis of TGF-β and BMP receptors and is then required for TGF-β and BMP activation. First, TGF-β and BMP signaling activation is dependent on clathrin-mediated endocytosis of TGF-β and BMP receptors. [38] [39] [40] Second, adaptor protein 2 (AP-2), an essential adaptor for clathrin-mediated endocytosis, is identified to interact with TGF-β and BMP receptors. 41, 42 Third, local clustering of Tfrc at cell surface promotes clathrin-coated pits initiation and clathrin lattices formation, [43] [44] [45] and a tight association between AP-2 and Tfrc was detected in our study (data not shown) and in previous literature. 46 Fourth, Tfrc deletion in NCCs suppresses both TGF-β and BMP signaling. So, it is plausible that Tfrc functions as a facilitator to control TGF-β and BMP receptor endocytosis via binding clathrin adaptor AP-2. Of note, Tfrc deletion may also affect caveolindependent endocytosis of TGF-β and BMP receptors. It has been documented that TGF-β and BMP receptors are internalized into cytoplasm through two distinct endocytic pathways, clathrin-mediated endocytosis and caveolin-dependent endocytosis. Clathrin-mediated endocytosis is important for the signaling activation, whereas caveolin-dependent endocytosis is required for receptor degradation. [38] [39] [40] We indeed found that Tfrc deletion strikingly decreased the protein level of both TGF-β and BMP receptors, indicating increased degradation of TGF-β and BMP receptors in response to Tfrc deletion. We hypothesize that this effect is possibly due to accelerated caveolindependent endocytosis of TGF-β and BMP receptors in Tfrc KO cells. Likely, Tfrc deletion switches the internalization pathway of TGF-β and BMP receptors from clathrin-mediated to caveolin-mediated endocytosis and thereby leads more receptors to be destined for degradation. Certainly, it is also possible that Tfrc negatively regulates caveolin-dependent endocytosis of TGF-β and BMP receptors in a direct manner. Further experiments will be needed to investigate these possible mechanisms in detail. Histological staining. For immunostaining, antibodies against Tfrc and AP-2α were purchased from Invitrogen (136800) and Epitomics (3154-1) and used at 1 : 400. Whole-mount immunohistochemistry was performed as previously described. 47 AP-2α antibody was used at 1 : 100. Whole-mount X-gal staining was performed using the In Situ β-galactosidase Staining Kit (Beyotime, Haimen, Jiangsu, China, RG0039), following the manufacturer's recommendations.
For histological examination, embryos and neonatal mice were fixed in 4% paraformaldehyde overnight at 4°C, then dehydrated in gradient sucrose solution and embedded in OCT, and cryosectioned at 14 μm. Sections were stained with hematoxylin and eosin following standard procedures.
Cell proliferation assay. Cell proliferation was evaluated by DNA synthesis activity through intraperitoneal BrdU injection (50 μg/g body weight) for 1.5 h, then mice were killed and embryos were fixed in 4% paraformaldehyde. Sections were treated with 2 N HCl at 37°C for 20 min then neutralized with 0.1 M sodium borate for 10 min. BrdU antibody (Santa Cruz, Dallas, TX, USA, sc32323, 1 : 200) was used to detect proliferative cells.
Palatal shelves culture. Palatal shelves culture was performed as previously described with minor modification. 33, 48 Briefly, palatal shelves were dissected from E13.5 embryos and placed on Millipore filters as the two segments just touching at the medial edge, cultured for 3 days and fixed in 4% paraformaldehyde followed by histological hematoxylin and eosin analysis.
Immunoblotting analysis. Antibodies used in immunoblotting analysis: Tfrc (Invitrogen, Waltham, MA, USA, 136800), Phospho-Smad5 (Epitomics, Burlingame, CA, USA, 2224-1), Phospho-Smad2 (Cell Signaling Technology, 3101), BMPR2 (Epitomics, S0778), TgfβR2 (Cell Signaling Technology, Burlingame, CA, USA, 3713), Runx2 (Millipore, Merck, KGaA, Darmstadt, Germany, 05-1478), β-actin (Santa Cruz, sc-47778). The immunoblotting analysis followed standard procedures.
Mandibular mesenchymal cell culture. Primary mandibular mesenchymal cell culture and osteochondrogenic differentiation were performed as previously described with minor modification. 49, 50 Briefly, mandible from E13.5 embryo was dissected and incubated with 0.25% trypsin at 37°C for 30 min. Isolated cells were plated at a density of 3 × 10 4 cells/cm 2 and cultured in complete medium (DMEM containing 10% FBS supplemented with penicillin, streptomycin, L-glutamate and sodium pyruvate). After 24 h (day 0), culture medium was supplemented with 10 mM β-glycerophosphate, 50 μg/ml ascorbic acid and 2.5 μM retinoic acid to induce osteochondrogenic differentiation. Followed by indicating days, cells were fixed then stained with Alcian blue and Alizarin red to evaluate cell differentiation, the staining and quantification method were performed as previously described. 50, 51 Real-time quantitative PCR. Total RNA was extracted using the RNeasy kit (QIAGEN, Hilden, Germany, 74134), and cDNA was synthesized with the TransScript One-Step gDNA Removal and cDNA Synthesis SuperMix (Transgen, Beijing, China, AT311). Quantitative real-time PCR was performed using SYBR Green PCR Master Mix (Applied Biosystems, Waltham, MA, USA, 4367659). Primer sequences used for qPCR were listed in Supplementary Material and Supplementary Table S2, according to previously published results. 22, 52 Expression levels of mRNA were normalized to β-actin.
Statistical analysis. Statistical analyses were performed using two-tailed Student's t-test. Data are presented as mean ± S.E.M; P-valueo0.05 indicated significant difference. 
